ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ATAI Life Sciences NV
Total Equity Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Total Equity
$243m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Total Equity
€35.7B
CAGR 3-Years
6%
CAGR 5-Years
-4%
CAGR 10-Years
6%
Merck KGaA
XETRA:MRK
Total Equity
€28.5B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
10%
MPH Health Care AG
XETRA:93M1
Total Equity
€251m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Total Equity
€551.6m
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Total Equity
€39.8m
CAGR 3-Years
51%
CAGR 5-Years
-14%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Total Equity?
Total Equity
243m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Total Equity amounts to 243m USD.

What is ATAI Life Sciences NV's Total Equity growth rate?
Total Equity CAGR 3Y
39%

Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for ATAI Life Sciences NV have been 39% over the past three years .

Back to Top